Omada Health (NASDAQ:OMDA) CEO Sells $509,530.64 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 21,572 shares of the firm’s stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $23.62, for a total value of $509,530.64. Following the sale, the chief executive officer directly owned 411,861 shares in the company, valued at approximately $9,728,156.82. The trade was a 4.98% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Omada Health Price Performance

Omada Health stock traded down $1.02 during trading hours on Thursday, reaching $22.29. The stock had a trading volume of 1,369,688 shares, compared to its average volume of 1,251,782. The company has a market cap of $1.36 billion, a price-to-earnings ratio of 445.80 and a beta of 1.86. The business’s 50 day moving average price is $22.59 and its 200-day moving average price is $17.46. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. The business had revenue of $87.83 million for the quarter, compared to analysts’ expectations of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. On average, sell-side analysts forecast that Omada Health, Inc. will post 0.09 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently commented on OMDA shares. JPMorgan Chase & Co. increased their price objective on Omada Health from $26.00 to $30.00 and gave the company an “overweight” rating in a report on Friday, August 14th. BMO Capital Markets reissued an “outperform” rating and issued a $24.00 price target on shares of Omada Health in a report on Friday, August 7th. Citigroup reaffirmed an “outperform” rating on shares of Omada Health in a research report on Friday, August 14th. Needham & Company LLC reissued a “buy” rating and set a $28.00 target price on shares of Omada Health in a research report on Friday, May 8th. Finally, Weiss Ratings raised shares of Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a report on Tuesday, August 11th. Eleven investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Omada Health has a consensus rating of “Moderate Buy” and an average price target of $26.50.

Hedge Funds Weigh In On Omada Health

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Raymond James Financial Inc. acquired a new stake in Omada Health during the 2nd quarter valued at approximately $32,000. Quarry LP purchased a new position in shares of Omada Health during the fourth quarter worth $29,000. Versant Capital Management Inc lifted its position in Omada Health by 319.3% during the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after purchasing an additional 2,283 shares during the period. Legal & General Group Plc purchased a new stake in Omada Health in the second quarter valued at $76,000. Finally, JPMorgan Chase & Co. acquired a new stake in Omada Health during the 3rd quarter worth about $82,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.